MedTrace Logo

Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff

NCT02367339 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2015-02-20

No results posted yet for this study

Summary

Evaluation of the prevalence of ESBL-Enterobacteriaceae colonization among ICU staff

Conditions

  • Antibiotic Resistance
  • Extended-spectrum Betalactamase
  • Enterobacteriaceae
  • Escherichia Coli

Interventions

OTHER

ESBL

Evaluation of the prevalence of ESBL-Enterobacteriaceae colonization among ICU staff

Sponsors & Collaborators

  • University Hospital, Estaing

    collaborator OTHER

  • Hopital Gabriel Montpied

    collaborator OTHER

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Julien PASCAL · University Hospital, Clermont-Ferrand

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02367339 on ClinicalTrials.gov